Clinical trial

Healthy Volunteer Study Using 3 Different Formulations of Firategrast

NCT01416363

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-05-20

PhasePHASE1

Study timeline

Study start (actual)2011-05-20Date precision: day

Registry last updated2017-07-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Relapsing-Remittingunresolved

Interventions

Firategrast immediate release tabletDRUG

Firategrast modified release tabletDRUG

Firategrast gastro-retentive solutionDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01416363 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.